Drw Securities, LLC Gilead Sciences, Inc. Transaction History

Drw Securities, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $598,122 - $729,395	8,356 New	8,356 $612,000
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $29,428 - $32,106	-398 Reduced 9.33%	3,869 $290,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $324,334 - $369,948	4,267 New	4,267 $329,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $270,624 - $291,973	-3,998 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $253,753 - $277,261	3,998 New	3,998 $275,000
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $320,412 - $365,094	-5,656 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $351,237 - $441,620	5,656 New	5,656 $357,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $500,809 - $581,532	-6,923 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $88,057 - $112,789	-1,406 Reduced 16.88%	6,923 $518,000
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $513,232 - $564,539	8,329 New	8,329 $541,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $1.33 Million - $1.63 Million	-18,312 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $1.3 Million - $1.53 Million	18,312	18,312 $1.31 Million

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Drw Securities, LLC with notifications on news.